10 Best Cannabis Stocks to Buy According to Billionaires

5. Canopy Growth Corporation (NASDAQ:CGC)

Number of Billionaire Holders: 5

Canopy Growth Corporation (NASDAQ:CGC), together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult use and medical purposes. The company has also positioned itself to be a top Canadian entrant in the US market with the acquisition of Wana Wellness, The CIMA Group, Mountain High Products, and most recently, Acreage.

Canopy Growth Corporation (NASDAQ:CGC) reported an EPS of -$0.78 in Q3 2025, significantly below estimates of -$0.39. However, the company’s revenue of $52.35 million beat expectations by $4.9 million, despite being down 21.77% YoY. CGC witnessed notable growth across its medical cannabis businesses, and its international markets net revenue also surged by 14% YoY, with strong growth in Poland and Germany. Moreover, Canopy’s Germany-based Storz & Bickel business, known for premium high-margin devices like the Volcano and Venti, delivered an overall net revenue growth of 19%.

Canopy Growth Corporation’s (NASDAQ:CGC) free cash flow for Q3 2025 was an outflow of around $19.52 million, an improvement of 17% compared to the prior year. To help bolster its balance sheet, the company launched a new at-the-market equity program last month, allowing the issuance and sale of up to $200 million in common shares.